Hypertension is a common condition that affects the body's arteries. It is primarily caused by high blood pressure. If you have high blood pressure, the force of the blood pressing against the artery walls will be too high. The heart has to work harder to pump blood.
Approximately 1.28 billion adults worldwide, aged 30-79 years, have hypertension, most living in low- and middle-income countries. Out of them, only 42% are diagnosed and treated.
Around 1 in 5 adults (21%) with hypertension have it under control. 46% of adults with hypertension are unaware of their condition.
Hypertension significantly increases the risks of heart, brain, kidney, and other diseases. Making it a major cause of premature deaths worldwide.
Norliqva is one such treatment!
We have covered this new treatment for hypertension in detail.
Continue reading to learn more!
More About New Drug for Hypertension
On 28th February 2022, FDA approved Norliqva, making it the first oral solution for treating hypertension.
Norliqva is a formulation of the approved calcium channel blocker amlodipine for treating hypertension in adults and children over 6 years old.
Norliqva ensures regular dosing and bioequivalence and counters the challenges of crushing or compounding amlodipine tablets. Norliqva is supplied as a peppermint-flavored oral solution containing 1 mg/mL amlodipine as the besylate salt.
Norliqva's peppermint flavor is kid-friendly and meets the unmet needs of pediatric and older patients with dysphagia or difficulty swallowing tablets.
Before taking this new treatment for hypertension, you should know about its safety and efficacy.
We have presented it below.
So please pay attention.
Key Points of the Clinical Trials
The antihypertensive effects of amlodipine have been witnessed in a randomized study involving 800 patients.
Studies showed that,
Just like any other treatment, this new drug for hypertension has side effects!
No matter how minimal, you should know them!
Side effects
Below mentioned are the known side effects of the Norliqva:
- Edema
- Dizziness
- Flushing
- Palpitations
- Fatigue
- Nausea
- Abdominal pain
- Tiredness
Note: Edema, flushing, palpitations, and tiredness may be more common in women than men.
What Should You Know Before Taking This New Drug for Hypertension?
Below are some points you should remember before considering this new treatment for hypertension:
- Norliqva is not indicated in patients with sensitivity to amlodipine.
- Symptomatic hypotension can occur, specifically in patients with severe aortic stenosis.
- Norliqva might affect slowly in patients with severe hepatic impairment.
- Progressive angina and acute myocardial infarction may develop after starting or increasing the dose of Norliqva, especially in patients with severe obstructive coronary artery disease.
